In Ewing sarcoma (EwS), development of new therapeutic strategies is crucial in order to refine treatment and improve patient survival, especially in metastatic or recurrent disease stages. Thus, preclinical drug screening is a key issue in EwS research. As especially in such drug screening assays, the cell viability aspect of cell proliferation is important, resazurin colorimetry shall be reviewed here as a fast, high-throughput method with automated readout to efficiently screen for potency of drugs via measurement of cell viability.
Julian Musa, Florencia Cidre-Aranaz. Drug Screening by Resazurin Colorimetry in Ewing Sarcoma. Methods in molecular biology (Clifton, N.J.). 2021;2226:159-166
PMID: 33326100
View Full Text